Company · CIK 1736243
Acurx Pharmaceuticals, Inc.
| CIK | 1736243 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | ACXP (Nasdaq) |
| First annual or quarterly report | 2021-08-13 |
Offerings
15 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298801 | 2026-09-08 | 2026-09-17 | 2 | |
| 333-295527 | 2026-05-04 | 2026-05-11 | 2 | |
| 333-295528 | 2026-05-04 | 2026-05-11 | 2 | |
| 333-288595 | 2025-07-09 | 2026-04-16 | 3 | |
| 333-293136 | 2026-02-02 | 2026-02-11 | 2 | |
| 333-290968 | 2025-10-20 | 2025-10-20 | 1 | |
| 333-288667 | 2025-07-15 | 2025-07-23 | 2 | |
| 333-287478 | 2025-05-21 | 2025-05-29 | 2 | |
| 333-286384 | 2025-04-04 | 2025-04-14 | 2 | |
| 333-284627 | 2025-01-31 | 2025-03-19 | 3 | |
| 333-265956 | 2022-07-01 | 2025-03-10 | 7 | |
| 333-278028 | 2024-03-18 | 2024-04-17 | 3 | |
| 333-273015 | 2023-06-29 | 2023-07-10 | 2 | |
| 333-267412 | 2022-09-14 | 2022-09-22 | 2 | |
| 333-256516 | 2021-05-27 | 2021-06-28 | 4 |
Filings
40| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-17 | EFFECTDeclared effective | 333-298801 | 9999999995-26-003000 |
| 2026-09-08 | S-1Registration filed | 333-298801 | 0001104659-26-105917 |
| 2026-05-11 | EFFECTDeclared effective | 333-295528 | 9999999995-26-001578 |
| 2026-05-11 | EFFECTDeclared effective | 333-295527 | 9999999995-26-001577 |
| 2026-05-04 | S-1Registration filed | 333-295528 | 0001104659-26-054887 |
| 2026-05-04 | S-1Registration filed | 333-295527 | 0001104659-26-054884 |
| 2026-04-16 | 424B5Shelf takedown | 333-288595 | 0001104659-26-044092 |
| 2026-02-11 | EFFECTDeclared effective | 333-293136 | 9999999995-26-000533 |
| 2026-02-02 | S-1Registration filed | 333-293136 | 0001104659-26-009266 |
| 2026-01-06 | EFFECTDeclared effective | 333-288595 | 9999999995-26-000076 |
| 2025-10-20 | S-1Registration filed | 333-290968 | 0001104659-25-100800 |
| 2025-07-23 | EFFECTDeclared effective | 333-288667 | 9999999995-25-002331 |
| 2025-07-15 | S-1Registration filed | 333-288667 | 0001104659-25-067841 |
| 2025-07-09 | S-3Shelf registered | 333-288595 | 0001104659-25-066693 |
| 2025-05-29 | EFFECTDeclared effective | 333-287478 | 9999999995-25-001775 |
| 2025-05-21 | S-1Registration filed | 333-287478 | 0001104659-25-051615 |
| 2025-04-14 | EFFECTDeclared effective | 333-286384 | 9999999995-25-001106 |
| 2025-04-04 | S-1Registration filed | 333-286384 | 0001104659-25-032184 |
| 2025-03-19 | EFFECTDeclared effective | 333-284627 | 9999999995-25-000717 |
| 2025-03-10 | 424B5Shelf takedown | 333-265956 | 0001104659-25-021975 |
| 2025-02-06 | EFFECTDeclared effective | 333-284627 | 9999999995-25-000343 |
| 2025-01-31 | S-1Registration filed | 333-284627 | 0001410578-25-000067 |
| 2025-01-07 | 424B5Shelf takedown | 333-265956 | 0001104659-25-001589 |
| 2024-04-17 | RWWithdrawn | 333-278028 | 0001104659-24-048304 |
| 2024-03-29 | S-1/AAmendment | 333-278028 | 0001104659-24-041187 |
| 2024-03-18 | S-1Registration filed | 333-278028 | 0001104659-24-035527 |
| 2023-11-15 | 424B5Shelf takedown | 333-265956 | 0001104659-23-118720 |
| 2023-07-10 | EFFECTDeclared effective | 333-273015 | 9999999995-23-002047 |
| 2023-06-29 | S-1Registration filed | 333-273015 | 0001104659-23-076317 |
| 2023-05-17 | 424B5Shelf takedown | 333-265956 | 0001104659-23-061859 |
| 2022-09-22 | EFFECTDeclared effective | 333-267412 | 9999999995-22-002802 |
| 2022-09-14 | S-1Registration filed | 333-267412 | 0001104659-22-100019 |
| 2022-07-25 | 424B5Shelf takedown | 333-265956 | 0001104659-22-082416 |
| 2022-07-11 | EFFECTDeclared effective | 333-265956 | 9999999995-22-002016 |
| 2022-07-01 | S-3Shelf registered | 333-265956 | 0001104659-22-076571 |
| 2021-06-28 | 424B4Final prospectus | 333-256516 | 0001104659-21-085915 |
| 2021-06-24 | EFFECTDeclared effective | 333-256516 | 9999999995-21-002496 |
| 2021-06-11 | S-1/AAmendment | 333-256516 | 0001104659-21-079723 |
| 2021-05-27 | S-1Registration filed | 333-256516 | 0001104659-21-072553 |
| 2021-04-05 | DRSDraft made public | 377-04584 | 0001104659-21-046188 |